The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
Open accessAbstract
1. Preamble 4361 2. Introduction 4363 3. Estimation of total cardiovascular risk and implications for dyslipidaemia management 4363 4. New low-density lipoprotein cholesterol-lowering therapies 4367 5. Combination of lipid-lowering therapies during index hospitalization for acute coronary syndromes 4369 6. Lipoprotein(a) 4370 7. Hypertriglyceridaemia 4371 8. Primary prevention in people with human immunodeficiency virus infection 4372 9. Patients with cancer at high or very high chemotherapy-related cardiovascular toxicity risk 4373 10. Dietary supplements 4373 11. Evidence tables 4374 12. Data availability statement 4374 13. Author information 4374 14. Appendix 4374 15. References 4375 Recommendation Table 1 — Recommendations for cardiovascular risk estimation in persons without known cardiovascular disease (see also Supplementary data online, Evidence Table 1) 4367 Recommendation Table 2 — Recommendations for pharmacological low-density lipoprotein cholesterol lowering (see also Supplementary data online, Evidence Table 2) 4369 Recommendation Table 3 — Recommendations for lipid-lowering therapy in patients with acute coronary syndromes (see also Supplementary data online, Evidence Table 3) 4370 Recommendation Table 4 — Recommendations for measurement of lipoprotein(a) (see also Supplementary data online, Evidence Table 4) 4370 Recommendation Table 5 — Recommendations for drug treatment of patients with hypertriglyceridaemia (see also Supplementary data online, Evidence Table 5) 4372 Recommendation Table 6 — Recommendations for statin therapy in primary prevention for people with human immunodeficiency virus infection (see also Supplementary data online, Evidence Table 6) 4373 Recommendation Table 7 — Recommendations for statin therapy in patients receiving cancer therapy (see also Supplementary data online, Evidence Table 7) 4373 Recommendation Table 8 — Recommendations for dietary supplements (see also Supplementary data online, Evidence Table 8) 4374 Table 1 Classes of recommendations 4362 Table 2 Levels of evidence 4362 Table 3 Cardiovascular risk categories 4364 Table 4 Intervention strategies as a function of total cardiovascular risk and untreated low-density lipoprotein cholesterol levels 4365 Figure 1 Treatment goals for low-density lipoprotein cholesterol across categories of total cardiovascular risk 4366 Figure 2 Average reduction in low-density lipoprotein cholesterol levels with different pharmacological therapies with proven cardiovascular benefits 4368 Figure 3 Association between Lp(a) levels and lifetime risk of major cardiovascular events 4371 Acute coronary syndromes Alanine aminotransferase Apolipoprotein B Apolipoprotein C-III Antiretroviral therapy Atherosclerotic cardiovascular disease Aspartate aminotransferase Aortic valve stenosis Coronary artery calcium Confidence interval Computed tomography Cardiovascular Cardiovascular disease Docosahexaenoic acid European Atherosclerosis Society European Medicines Agency Eicosapentaenoic acid European Society of Cardiology Familial chylomicronaemia syndrome US Food and Drug Administration Familial hypercholesterolaemia High-density lipoprotein cholesterol Human immunodeficiency virus Hazard ratio Low-density lipoprotein cholesterol Lipoprotein(a) Left ventricular ejection fraction Monoclonal antibody Major adverse cardiovascular event(s) Myocardial infarction Percutaneous coronary intervention Proprotein convertase subtilisin/kexin type 9 Peroxisome proliferator-activated receptor n-3 polyunsaturated fatty acid People with HIV Systematic Coronary Risk Evaluation 2 Systematic Coronary Risk Evaluation 2-Older Persons Total cholesterol Type 1 diabetes mellitus Type 2 diabetes mellitus Upper limit of normal Guidelines evaluate and summarize available evidence with the aim of assisting health professionals in proposing the best diagnostic or therapeutic approach for an individual patient with a given condition. The European Society of Cardiology (ESC) Guidelines are intended for use by health professionals but do not override their individual responsibility to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with the patient or the patient's caregiver where appropriate and/or necessary aiming at shared care decisions. It is also the health professional's responsibility to verify the rules and regulations applicable in each country to drugs and devices at the time of prescription and to respect the ethical rules of their profession. The ESC Guidelines represent the official position of the ESC on a given topic. Guideline topics are selected for updating after annual expert review of new evidence conducted by the ESC Clinical Practice Guidelines (CPG) Committee. ESC Policies and Procedures for formulating and issuing the ESC Guidelines can be found on the ESC website (https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Guidelines-development/Writing-ESC-Guidelines). Interim
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, the guidelines highlight that variability in LDL-C lowering is observed across all treatment options, likely reflecting differences in background LLT regimens [45].”
From Systematic literature review on the real-world effectiveness and safety of bempedoic acid (2026) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In line with this, they emphasize the importance of monitoring LDL-C response 4 to 6 weeks after initiation or intensification and making timely treatment adjustments to achieve recommended targets [45].”
From Systematic literature review on the real-world effectiveness and safety of bempedoic acid (2026) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The recent ESC/EAS 2025 Focused Update Guideline [9] emphasizes that elevated TG and TRLs contribute independently to cardiovascular risk, even in patients achieving LDL-C targets.”
From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The recent 2025 ESC/EAS Focused Update confirms this guidance, emphasizing the persistent role of statins as the cornerstone therapy for cardiovascular risk reduction in the presence of elevated TG, not only by targeting LDL-C but also by modulating TRLs and reducing the atherogenic potential of the lipid profile [9].”
From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The recommendations position bempedoic acid alongside other established LLTs with demonstrated cardiovascular-risk reduction such as statins, ezetimibe, and PCSK9i.”
From Systematic literature review on the real-world effectiveness and safety of bempedoic acid (2026) · cites this paper as [45]
The cited source says what the claim attributes to it.
In the citing paper
“Guidelines also recommend that the choice of treatment should not only be made based on the magnitude of additional LDL-C lowering needed, but also patient preference, treatment availability, and cost [45].”
From Systematic literature review on the real-world effectiveness and safety of bempedoic acid (2026) · cites this paper as [45]
The cited source says what the claim attributes to it.
In the citing paper
“The 2025 ESC/EAS guidelines for the management of dyslipidemia provide new recommendations for bempedoic acid in both patients unable to take statins and as an adjunct to maximally tolerated statin therapy, with or without ezetimibe, including use in high- and very high-risk patients [45].”
From Systematic literature review on the real-world effectiveness and safety of bempedoic acid (2026) · cites this paper as [45]
The cited source says what the claim attributes to it.
In the citing paper
“the 2025 ESC/EAS Focused Update [9] emphasizes that consistent cardiovascular benefit has not been demonstrated in the overall population, and fibrate therapy should therefore be reserved for carefully selected patients with persistent hypertriglyceridaemia or features of atherogenic dyslipidemia despite optimal LDL-C lowering”
From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“Overall, the joint guideline recognizes TG/TRL-mediated risk as a modifiable component of residual cardiovascular risk, addressed pragmatically through non–HDL-C/apoB targets and selective TG-lowering therapies integrated with intensive LDL-C reduction, with non-fasting testing as the default approach.”
From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Self-citationCholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Self-citation2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
Self-citationEzetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962
Self-citation2024 ESC Guidelines for the management of chronic coronary syndromes
Vrints, C. J., Andreotti, F., Koskinas, K. C., Rosselló, X., Adamo, M., Ainslie, J., BANNING, A. P., Budaj, A., Buechel, R. R., Chiariello, G. A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae177 · Cited by 3,521
Self-citationLyon, A. R., López‐Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J. K., Boriani, G., Cardinale, D. M., Córdoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,457
Self-citationCardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
Cited by
Sorted by citations
Items 401–500 of 817
Lombardi, R., Cinque, F., Cespiati, A., Bertelli, C., Pisano, G., Oberti, G., Fatta, E., Currà, J., Calzavara, E., Alletto, F., et al. (2026) · Hepatology International · doi:10.1007/s12072-026-11084-6
van de Loo, I., & Harbeck, B. (2026) · Springer eBooks · doi:10.1007/978-3-662-71684-7_11
García-Benito, C., Oxley-Babsky, L., Crespo-Martín, M., del-Molino-Serrano, E., Santos-Villanueva, R., Olloqui-Fuentes, A., Guillén-Lorenzo, L., & García-Rio, F. (2026) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-026-00516-3
Jonani, B., Cissy, M., Nakibuuka, G., Nabakka, D., Shafina, N., Bwire, H. R., Kasule, E. C., Proscovia, N., Ssentongo, F., Peace, N. P., et al. (2026) · Scientific African · doi:10.1016/j.sciaf.2026.e03373
Wu, Y., Yeh, C., Hsu, C.-Y., Lin, C. Y., Huang, C., Tang, S., Huang, Y. T., Lin, C. Y., Yu, C.-H., Huang, C. Y., et al. (2026) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2026.04.111
Caggianelli, G., Iorfida, M., Cavaliere, R., Manzoli, A., D’Angelo, A., Scerbo, F., Marti, F., Mancin, S., Cangelosi, G., Rocco, G., et al. (2026) · Medicina · doi:10.3390/medicina62050843
Azulay, M., Yekutiel, N., Elboim, M., Hoshen, M., Gazit, S., & Shavit, O. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1672698
Colivicchi, F., Fusco, S. A. D., Arca, M., Averna, M., Scicchitano, P., Nardi, F., & Catapano, A. L. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104777
Self-citationInterventionelle Therapie der extrakraniellen Karotisstenose
Andrassy, M., Langhoff, R., & Korosoglou, G. (2026) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-2749-4230
Ngọc, T. T. H., Hoàng, P. M., Hằng, P. T. P., Hải, P. T., & Nghĩa, N. N. (2026) · Tạp chí Nghiên cứu Y học · doi:10.52852/tcncyh.v201i4.4825
Essential to identify high lipoprotein(a) in children with hypercholesterolaemia
Nordestgaard, L. T., Mourre, F., & Nordestgaard, B. G. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag251
Self-citationCaklili, O. T., Haymana, C., Demirci, İ., Kebapçı, M. N., Sarıakçalı, B., Evren, B., Dizdar, O. S., Salman, S., Ersoy, C., Satman, İ., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70806
喻, 慧. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1651815
Waßmann, S. (2026) · Die Innere Medizin · doi:10.1007/s00108-026-02118-0
Prastaro, M., Grattagliano, M. M., Kats, O., Pignatiello, A., & Portincasa, P. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04376-0
徐, 郝. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1651864
Musumeci, G., Pradelli, L., Lee, K., & Povero, M. (2026) · Clinical Drug Investigation · doi:10.1007/s40261-026-01559-7
Zhang, Y., Wei, J., Wang, A., Li, B., Yu, R., Qiao, L., Xing, Y., Wang, X., Li, X., & Zhu, M. (2026) · Research Square · doi:10.21203/rs.3.rs-9524517/v1
Maki, K. C., & Duell, P. B. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.04.019
Albuminuria drives hyperlipidemia in patients with Alport syndrome
Groß, O., Jens, A., Čerkauskaitė, A., Gillion, V., Choi, M., Halbritter, J., Zhang, Y., Wang, F., Ding, J., Bever, I., et al. (2026) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfag100
Le HDL n’est plus le « bon cholestérol » !
Renucci, J.-F., Bertolino, J., & Sarlon, G. (2026) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2026.100814
Chai, D.-Y., Han, H.-Y., Xu, C., Liu, S., Duan, H., & Wang, L. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.05.008
Rehman, A. U., Morgan, H. D., Thayyil, S., Dales, J., & Kong, M. (2026) · British Journal of Diabetes · doi:10.15277/bjd.2026.501
Ciuceis, C. D., & Rizzoni, D. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag271
Building Global Bridges in Clinical Guidance
Tiosano, S., Morris, P. B., Koskinas, K. C., Tokgözoğlu, L. S., Blumenthal, R. S., & Gianos, E. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.03.055
Self-citationFreijo, M. D. M., Cardona, P., Castellanos, M., de Torres-Chacón, R., Gil-Núñez, A., Guillán, M., Martínez‐Sánchez, P., Palacio-Portilla, E. J., Purroy, F., Segura, T., et al. (2026) · Neurología · doi:10.1016/j.nrl.2026.502076
Childhood cancer survivors and cardiovascular prevention: a missing high-risk population
Bonanni, L., & Cutolo, A. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag281
Freijo-Guerrero, M., Cardona, P., Castellanos, M., de Torres-Chacón, R., Gil-Núñez, A., Guillán, M., Martínez-Sánchez, P., Palacio-Portilla, E. J., Purroy, F. F., Segura, T., et al. (2026) · Neurología (English Edition) · doi:10.1016/j.nrleng.2026.502076
Weekly Journal Scan: Translating LDL-cholesterol targets into vascular event reduction
Pedicino, D., & Volpe, M. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag369
Cui, K., Chen, M., Zhang, L., An, Y., Li, S., Liu, X., Xu, X., Wu, H., Li, Z. L., & Li, F. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110414
Diabetic neuropathy of the lower extremities: diagnostic route of the patient (clinical case)
Nechyporenko, M., Lutsenko, V., Ozeryanska, O., & Saienko, Y. A. (2026) · Diabetes Obesity Metabolic Syndrome · doi:10.57105/2415-7252-2026-2-01
Cersosimo, A., Rovelli, R., Drera, A., Gorga, E., Brangi, E., Metra, M., & Vizzardi, E. (2026) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001873
Self-citationBershtein, L. L., Zbyshevskaya, E. V., & Gumerova, V. E. (2026) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov690537
van Kooten, H. A., van Zoest, D., Michels, M., van der Beek, N. A. M. E., Brusse, E., van der Ploeg, A. T., Langendonk, J. G., van Doorn, P. A., & Wagenmakers, M. A. E. M. (2026) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-026-04400-8
High Lipoprotein(a) in Cardiovascular Disease
Thomas, P. E., & Kamstrup, P. R. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.108325
Mesquita-Lousada, A., Rocha-Melo-Sousa, A., Teixeira, C., Guimarães, T. R., Marques-Vieira, M., Andrade, J. P., Ribeiro, H., Neiva‐Sousa, M., & Rocha-Neves, J. P. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15114205
Xie, Y., Li, M., Luo, F., Pi, J., & He, Q. J. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1843566
Genomic and Sex Contributions to Interindividual Variability in Pitavastatin Bioavailability
González‐Iglesias, E., de Villar, S. M., Ochoa, D., Román, M. C., Novalbos, J., Martín‐Vílchez, S., de Miguel, A., & Abad‐Santos, F. (2026) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70251
Chen, Y.-Y., Chien, K., Chien, K., Yu, Q., Hsieh, Y., Chen, F.-Y., Lin, Y.-J., Lip, G. Y. H., & Chen, S.-A. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02984-5
Self-citationParaskevas, K. I., Sultan, S., Podlasek, A., Dardik, A., Myrcha, P., Perler, B. A., White, C. J., Oria, M. D. ́., Lazzaro, V. D., Setacci, F., et al. (2026) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2026.04.044
Xu, J.-L., Luo, C., Duan, C., Xu, S.-Y., Wu, Z.-Q., Ye, L., Li, Z.-P., Wang, M.-S., Yu, X.-M., & He, D. (2026) · World Journal of Diabetes · doi:10.4239/wjd.119712
Marais, A. D., Blom, D. J., Blackhurst, D., & Raal, F. J. (2026) · South African Medical Journal · doi:10.7196/samj.2026.v116i5.4971
Schäfer, A., Großhennig, A., Theis, L., Schindler, C., Grahl, E., Stichtenoth, D. O., König, T., Geller, W.-A., Schmidt, H. H. J. G., Bavendiek, U., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1755590
Lu, Y., Jiang, D., Zhang, J., & Liang, Y. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s605053
Raja, V., Aguiar, C. A., Alsayed, N., Chibber, Y. S., ElBadawi, H., Farnier, M., Pushpa, K., Tokgözoğlu, L. S., Zambon, A., Berrou, J., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1837004
Self-citationYoon, S., Kang, M., & Yang, H. S. (2026) · Metabolites · doi:10.3390/metabo16060390
Derosa, G., D’Angelo, A., Maffioli, P., Badagliacca, R., Buscemi, S., Ferri, C., Friso, S., Moschetta, A., Muscaritoli, M., Filardi, P. P., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9833326/v1
Casu, G., Idini, C., Santoru, A., Serra, G., Bilotta, F., Poddighe, C., Merella, P., Murtas, V. D., Rubbino, F., Micheluzzi, V., et al. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104820
Self-citationToscano, A., Bosco, G., Barbagallo, F. D. G., Marco, M. D., Scilletta, S., Pino, A. D., Piro, S., Scuruchi, M., Squadrito, G., Scicali, R., et al. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104822
Liu, X., Yuanlin, G., Zhao, B., Teng, H., Liu, W., Xiao, K., & Ma, C. (2026) · Atherosclerosis Plus · doi:10.1016/j.athplu.2026.100570
Masana, L., Ribalta, J., & Ibarretxe, D. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00102-6
Lanthier, L., Perron, P.-N., Mutchmore, A., Plourde, M.-É., & Cauchon, M. (2026) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2026.05.017
Gencer, B., Ribero, V. A., & Efthimiou, O. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag290
Akinmolayemi, O., Oliva, A., Sartori, S., Vasa, D., Feng, Y., Sweeny, J. M., Hooda, A., Bhatt, D. L., Dangas, G., Mehran, R., et al. (2026) · The American Journal of Medicine · doi:10.1016/j.amjmed.2026.05.044
Kwon, Y., Kim, N., Kim, D.-H., Kim, B., Park, J. S., Park, Y. J., Park, B. E., Kim, H. N., Lee, J. H., Yang, D. H., et al. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06087-y
Rees, M., Al-Jarshawi, M., Asher, E., Wijeysundera, H. C., & Mamas, M. A. (2026) · Heart · doi:10.1136/heartjnl-2026-bcs.257
Cardiovascular risk factors in Greece: looking beyond the classics. A narrative review
Michas, G., Trikas, G., & Trikas, A. G. (2026) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2026.06.002
Toscano, A., Delfa, R. L., Stephens, H., Orlandi, M., Corsi, M., Mascherini, G., Zurli, T., Avossa, A., Fiorillo, C., Becatti, M., et al. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04423-w
Ho, A. K. H., Leow, A. S., Tan, S. M.-L., Sim, V. W. J., Yan, Q., Sia, C. H., Simon, O., & Poh, K.-K. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1815535
Biscetti, F., Rando, M. M., Nicolazzi, M. A., Angelini, F., Iezzi, R., Eraso, L. H., DiMuzio, P. J., Pitocco, D., Massetti, M., Gasbarrini, A., et al. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03233-w
Frolenko, A. M., & Kolesnyk, M. Y. (2026) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2026.3.352338
Calcaterra, I. L., Luca, C. D., Valletta, L., D’Errico, G., Ferrandino, M., Cardiero, G., Taranto, M. D. D., Fortunato, G., Iannuzzo, G., Tufano, A., et al. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04417-8
Xu, Y., Yang, H., Xu, Q., Yu, X., Dai, S., Zhang, X., Shen, W., & Zhu, X. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00727-2
Kataoka, Y., Nicholls, S. J., Kitahara, S., Katasako-Yabumoto, A., Funabashi, S., Mitsui, K., Murai, K., Iwai, T., Sawada, K., Matama, H., et al. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.06.008
Comparison of Four Formulas for Calculating LDL-Cholesterol with the Direct Homogeneous Method
Mirjanić-Azarić, B., Lukić, V., Ivetic, B., Sukur, A., Milinković, N., Savic, Z. R., Avram, S., Bogavac‐Stanojević, N., & Ninić, A. (2026) · Biomedicines · doi:10.3390/biomedicines14061347
Koskinas, K. C., & Windecker, S. (2026) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2026.05.005
Self-citationМІСЦЕ ТА РОЛЬ LP(A) В РОЗВИТКУ ТА ПРОГРЕСУВАННЮ АТЕРОСКЛЕРОЗУ
Ткач, Є. (2026) · Перспективи та інновації науки · doi:10.52058/2786-4952-2026-5(63)-3711-3726
Batran, R. A., Tahoun, S., Othman, A., AMIN, Y. M., Khalil, A., Bahr, A., Kamel, M., & Elsokary, M. (2026) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000001046
Association of the apolipoproteins with retinal arteriosclerosis in a health examination population
Sun, X., Guo, L., Lv, H., Zhang, X., Wu, C., & Liu, X. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1852420
Ганиева, М. Р. (n.d.) · CyberLeninK (CyberLeninka)
Beyond the Agatston comfort zone: refining coronary calcium scoring below 130 HU
Gräni, C., & Koskinas, K. C. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag335
Self-citationIs the lipoprotein(a)–venous thromboembolism association truly hormone-dependent?
Çağlar, S. O., & Hıra, S. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag490
Mancini, G. B. J., Lincoff, A. M., Goldberg, A. C., Broestl, C., Li, N., Duell, P. B., Laufs, U., Catapano, A. L., Leiter, L. A., Banach, M., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047897
Self-citationTiecco, G., Riva, M., Cesanelli, F., Rossi, L., Colangelo, C., Reale, S. A., Gottardi, F., Delbarba, A., Cappelli, C., Focà, E., et al. (2026) · Basic and Clinical Andrology · doi:10.1186/s12610-026-00320-6
Liu, X., Yin, L., & Hao, X. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06101-3
Orhan, B., Deniz, L., Aydin, C., & Kocakoç, İ. D. (2026) · Diagnostics · doi:10.3390/diagnostics16132031
Cozma, D. C., Lighezan, D., Tudoran, C., Voinescu, O. R., & Mornoş, C. (2026) · Medicina · doi:10.3390/medicina62071257
Levels and tracking of Lipoprotein (a) serum concentrations from infancy to adolescencePreprint
Jumpponen, T., Juonala, M., Salo, P., Lisinen, I., Laitinen, T. T., Pahkala, K., Rovio, S., Viikari, J. S. A., Rönnemaa, T., Niinikoski, H., et al. (2026) · medRxiv · doi:10.64898/2026.06.25.26356629
Self-citationDu, L., Rodríguez, F., Ray, K. K., Yang, E., & Kim, D. S. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101730
He, B.-B., & Wu, G.-Y. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06162-4
MASLD as a Cardiometabolic Continuum: Three Clinical Scenarios and Therapeutic Approaches
Shcherbynina, M. B. (2026) · Family medicine European practices · doi:10.30841/2786-720x.2.2026.365349
Lipid-lowering for people with chronic kidney disease: a narrative review
Tunnicliffe, D. J., Krishnasamy, R., & Strippoli, G. F. (2026) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2024.000059
Alfehaid, L., Habeeb, E. A., Badawoud, A. M., Alsuhaibani, S. A., Almutairi, R., Alyahya, R., Alquraishi, S., Alharbi, H. A., AlShammari, S., Alfulayyih, H., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19071035
Fujii, M., Yamamoto, H., Sawada, T., Yasaka, Y., Uzu, K., Miyata, T., Inoue, T., & Takaya, T. (2026) · JACC Asia · doi:10.1016/j.jacasi.2026.05.020
Metabolic and Safety Outcomes of Statin–Ezetimibe Versus High‐Intensity Statin in Older Patients
Cha, J., Shin, Y. H., Joo, H. J., Park, J. H., Yu, C. W., Lee, P. H., Lee, S., Lee, C. W., Moon, J. Y., Lee, J., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.048711
Castiello, D. S., Greco, F. F. G., Curcio, A., & Polimeni, A. (2026) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.70726
Kreutz, R. H., Brunström, M., & Januszewicz, A. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag342
Swapna, B., Prathikantam, B., Gundela, P., Lubna, H., & Ashwini, S. (2026) · World Journal of Current Medical and Pharmaceutical Research · doi:10.37022/wjcmpr.v8i2.399
Laborda, C. G., Miguelena, P. R. D. G., Villa, C. R., Val, I. S., Sánchez, M. B., Hycka, J. M., & López, A. C. (2026) · Medicina Intensiva · doi:10.1016/j.medin.2026.502528
Tocci, G., Nardoianni, G., Pala, B., Zuppini, E., Gualtieri, P., Renzo, L. D., Valenti, V., Basolo, A., Salvetti, G., Santini, F., et al. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104857
Conti, D. G. A., Tosetti, L. S., Jablonka, F., Hix, S., Wolska, A. T., Amar, M. J., Remaley, A. T., & Fonseca, F. L. A. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121215
Al-Dawoudi, A., Dalain, M., Varlamov, D., Alhallak, S., & Nanna, M. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06223-8
Đặc điểm tỷ số ApoB/ApoA1 ở bệnh nhân cao tuổi mắc hội chứng động mạch vành cấp
Trí, P. H. M., An, T. V., & Tân, N. V. (2026) · Tạp chí Nghiên cứu Y học · doi:10.52852/tcncyh.v203i6.5046
Akkaya, F., Bahadır, N., Sağlam, M. K., Cömert, A. D., Şentürk, N., & Yıldırım, O. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15135251
Gohman, U., Nashtar, M. A., Liedtke, P., Azizy, O., Trippe, J., Strauch, J., Jánosi, R. A., Iliakis, P., Dimitriadis, K. P., Tsioufis, K. P., et al. (2026) · Medicina · doi:10.3390/medicina62071293
The Genetic Stamp of Lipoprotein(a): Moving Beyond LDL for Cardiovascular Risk Estimation
Solimene, A., Luisi, E., Morello, M., Titolo, G., Serpico, C., Granata, M., Acampora, B., Bernazeaut, J., Loffredo, F. S., Golino, P., et al. (2026) · Targets · doi:10.3390/targets4030023
Nuevas perspectivas en el abordaje de la dislipemia y el papel de los inhibidores de PCSK9
Espinosa-García, S., Betancor-Pérez, C., Larrañaga-Zulaica, Y., & Yanes-Rodríguez, M. (2026) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2026.102799
Gu, T. F., Chen, Y. C., Zhang, N. X., Alam, U., Proietti, R., Liu, T., Chen, K., & Lip, G. Y. H. (2026) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70687
Self-citation
Metadata
- Authors
- Mach, F., Koskinas, K. C., Roeters van Lennep, J. E., Tokgözoğlu, L., Badimon, L., Baigent, C., Benn, M., Binder, C. J., Catapano, A. L., De Backer, G. G., Delgado, V., Fabin, N., Ference, B. A., Graham, I. M., Landmesser, U., Laufs, U., Mihaylova, B., Nordestgaard, B. G., Richter, D. J., Sabatine, M. S., ESC/EAS Scientific Document Group, Mueller, C. E., Drexel, H., Abreu, A., Adamo, M., Aktaa, S., Asselbergs, F. W., Baldini, A., Boriani, G., Brida, M., Brodmann, M., Cenko, E., Dagres, N., Dopheide, J., Ebenbichler, C., Gandjbakhch, E., Gorog, D. A., Gouni-Berthold, I., Guasti, L., Heidecker, B., Ibanez, B., James, S., Juni, P., Kałużna-Oleksy, M., Krychtiuk, K. A., Lip, G. Y. H., Lorusso, R., Mahfoud, F., Metra, M., Moelgaard, I., Morais, J., Neubeck, L., Nissen, S. E., Osto, E., Parhofer, K. G., De Isla, L. P., Pesce, M., Petrulioniene, Z., Prescott, E., Rietzschel, E., Rocca, B., Rodriguez Palomares, J. F., Rossello, X., Sannino, A., Semb, A. G., Siller-Matula, J. M., Socrates, T., Tanner, F. C., Wojta, J., Zambon, A., Zeppenfeld, K., Laredj, N., Hayrapetyan, H., Speidl, W. S., Samadov, F., van de Borne, P., Kusljugic, Z., Postadzhiyan, A., Heracleous, H., Ostadal, P., Henriksen, F. L., Mohamed, M. S., Viigimaa, M., Juonala, M., Boccara, F., Chukhrukidze, A., Weingärtner, O., Marketou, M., Kiss, R. G., Sigurdsson, A. F., Maher, V., Henkin, Y., Nodari, S., Bekbossynova, M., Ibrahimi, P., Mirrakhimov, E., Jegere, S., Arnaout, S., Bheleel, O., Plisiene, J., Visser, L., Abela, M., Ivanov, V., Boskovic, A., Mbarek, N., Leening, M. J. G., Bosevski, M., Vesterbekkmo, E. K., Kubica, J., Ferreira, J., Pop, D., Stefanelli, U. M., Giga, V., Pella, D., Fras, Z., Fernandez-Olmo, R., Nilsson, L., Sudano, I., Marjeh, M. Y. B., Triki, F., Degertekin, M. M., Mitchenko, O., Banerjee, A., & Shek, A.
- Affiliations
- (Switzerland)
- (Netherlands)
- (Türkiye)
- (Spain)
- (United Kingdom)
- (Denmark)
- (Austria)
- (Italy)
- (Belgium)
- (Ireland)
- (Germany)
- (Greece)
- (United States of America)
- (Portugal)
- (Croatia)
- (France)
- (Sweden)
- (Poland)
- (Austria/Switzerland)
- (Italy/Saudi Arabia)
- (Lithuania)
- (Norway)
- Corresponding author
- Mach, François
- Koskinas, Konstantinos C
- ORCID
- Mach, François
- Koskinas, Konstantinos C
- Roeters van Lennep, Jeanine E
- Tokgözoğlu, Lale
- Badimon, Lina
- Baigent, Colin
- Benn, Marianne
- Binder, Christoph J
- Catapano, Alberico L
- De Backer, Guy G
- Delgado, Victoria
- Fabin, Natalia
- Graham, Ian M
- Landmesser, Ulf
- Laufs, Ulrich
- Mihaylova, Borislava
- Nordestgaard, Børge Grønne
- Richter, Dimitrios J
- Sabatine, Marc S
- Mueller, Christian Eugen
- Drexel, Heinz
- Abreu, Ana
- Adamo, Marianna
- Aktaa, Suleman
- Asselbergs, Folkert W
- Boriani, Giuseppe
- Brida, Margarita
- Brodmann, Marianne
- Cenko, Edina
- Dagres, Nikolaos
- Dopheide, Jörn
- Ebenbichler, Christoph
- Gandjbakhch, Estelle
- Gorog, Diana A
- Guasti, Luigina
- Heidecker, Bettina
- James, Stefan
- Krychtiuk, Konstantin A
- Lip, Gregory Y H
- Lorusso, Roberto
- Mahfoud, Felix
- Metra, Marco
- Neubeck, Lis
- Nissen, Steven E
- Osto, Elena
- Parhofer, Klaus G
- Pesce, Maurizio
- Prescott, Eva
- Rietzschel, Ernst
- Rocca, Bianca
- Sannino, Anna
- Semb, Anne Grete
- Siller-Matula, Jolanta M
- Socrates, Thenral
- Tanner, Felix C
- Wojta, Johann
- Zambon, Alberto
- Zeppenfeld, Katja
- Hayrapetyan, Hamlet
- Speidl, Walter Stefan
- Samadov, Fuad
- van de Borne, Philippe
- Postadzhiyan, Arman
- Henriksen, Finn Lund
- Juonala, Markus
- Boccara, Franck
- Chukhrukidze, Archil
- Weingärtner, Oliver
- Marketou, Maria
- Nodari, Savina
- Bekbossynova, Makhabbat
- Mirrakhimov, Erkin
- Bheleel, Osama
- Abela, Mark
- Ivanov, Victoria
- Leening, Maarten J G
- Bosevski, Marijan
- Vesterbekkmo, Elisabeth K
- Kubica, Jacek
- Ferreira, Jorge
- Pop, Dana
- Giga, Vojislav
- Pella, Daniel
- Sudano, Isabella
- Triki, Faten
- Mitchenko, Olena
- Banerjee, Amitava
- Shek, Aleksandr
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2025-08-29
- Volume
- 46
- Issue
- 42
- Pages
- 4359-4378
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W4413804012
- Cited by
- 688
- References
- 136
- Citations by year
- 2026: 601 · 2025: 87
- FWCI
- 649.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, other-oa)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- dyslipidemia, dyslipidemia management, cardiovascular risk prediction, LDL-C lowering therapy, acute coronary syndrome, lipoprotein(a), hypertriglyceridemia, HIV infection, cancer patients, statins, dietary supplements, treatment goals, cardiovascular risk reduction, cardiovascular mortality, cardiovascular hospitalization, cardiovascular disease prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
